Invention Grant
- Patent Title: Method for generating high affinity antibodies
-
Application No.: US15526522Application Date: 2015-11-13
-
Publication No.: US10752698B2Publication Date: 2020-08-25
- Inventor: Gang Chen , Robert Babb , James P. Fandl
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Agent Todd R. Samelman
- International Application: PCT/US2015/060523 WO 20151113
- International Announcement: WO2016/077666 WO 20160519
- Main IPC: C07K16/32
- IPC: C07K16/32 ; G01N33/50 ; C07K16/00 ; C07K16/22

Abstract:
The present disclosure relates to a method for identifying cells that express antigen-specific antibodies with a high binding affinity for a monomeric antigen. Using fluorescence activated cell sorting, cells expressing high affinity antigen-specific antibodies are selected from a population of immune cells isolated from a mammal that has been immunized with or otherwise exposed to the antigen. Nucleic acids encoding the high affinity antibodies can then be cloned into other lymphoid and non-lymphoid cells where the antibody can be expressed and from which the antibodies can be secreted.
Public/Granted literature
- US20170327593A1 METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES Public/Granted day:2017-11-16
Information query